Anti-cancer drug development & formulation news
Curated headlines on oncology formulations, injectables, biosimilars and manufacturing — aggregated from leading global pharmaceutical publications and refreshed continuously.
Live feed · updated hourly from global industry sources
European drug manufacturers under threat from proposed US supply chain bill
US efforts to scrutinise overseas drug manufacturing could expose Europe’s role in supplying FDA-approved innovator and biosimilar drugs.
Read full articleAs chemo overtreatment comes into focus, Atossa bets on tamoxifen’s active form
As evidence mounts that some hormone receptor-positive, HER2-negative breast cancer patients are being overtreated with chemotherapy, researchers are working to identify which patients can safely avoid it, and to expa…
Read moreHow ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
More than a decade ago, the American Society of Clinical Oncology (ASCO) launched CancerLinQ, a platform designed to pool electronic health record data from oncology practices, turning routine patient encounters into …
Read moreModerna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
At its recent annual Science Day, Moderna signalled a strategic expansion beyond its established vaccine and rare disease franchises, unveiling new programs in in vivo CAR-T and solid tumor oncology. The firm also rev…
Read moreHeadlines are aggregated from third-party publications and link to their original sources. Salus Pharmaceuticals is not affiliated with these outlets.